Magnetoencephalography (MEG), which records magnetic fields created by brain activity outside of the head, is currently used in normal clinical practice across the globe. MEG has become an accepted and necessary aspect of the presurgical assessment of patients with epilepsy and brain tumors. DataM Intelligence examines studies that demonstrate an improvement in the postsurgical outcomes of epileptic patients by localizing epileptic discharges.
Magnetoencephalography can scan and localize brain activity related to several cognitive functions, including language processing, memory, attention, and sensory perception. By monitoring the exact timing and location of brain activity, researchers may learn more about how various areas of the brain interact and contribute to certain cognitive processes.
A Snapshot of the Magnetoencephalography Market
The magnetoencephalography market has been expanding rapidly in recent years, driven primarily by its increasing prevalence of dementia and technological advancements. As these drivers continue to gain traction, the market size is expected to grow significantly in the coming years. According to DataM Intelligence, the global magnetoencephalography market is poised for substantial growth, making it an attractive opportunity for investors and businesses alike.
In recent years, the global magnetoencephalography market has witnessed a series of product launches and approvals that have contributed to its growth. DataM Intelligence's in-depth market analysis reveals the major magnetoencephalography market drivers, challenges, trends, and opportunities. Our market intelligence report evaluates the magnetoencephalography market size, growth, and share, providing crucial insights for businesses to make informed decisions and capitalize on the existing and upcoming opportunities in the magnetoencephalography market.
The Increasing Prevalence of Dementia is Driving the Global Magnetoencephalography Market Growth
Dementia, a form of degenerative brain disorder, has a substantial influence on memory, behavior, emotional processing and regulation, and cognition. Alzheimer's disease is the most common kind of dementia, although there are others. There are presently 55 million individuals living with dementia worldwide, with 10 million new cases recorded each year. This figure will climb to 75 million in 2030 and 139 million in 2050. The bulk of the growth will be accounted for by developing countries.
People's mental health is often influenced by their social and environmental circumstances, as well as their exposure to risk factors. Risk factors for mental and neurological diseases include genetics, old age, cigarette, drug, and alcohol use, poor diet, and physical inactivity. Environmental exposures, such as pollution and cranial traumas, endanger people as well.
Technological Advancements are driving the global Magnetoencephalography Market Growth
The advancement of neuroimaging is well-positioned to translate breakthroughs in neurodegenerative cellular genetics and molecular biology into better dementia diagnosis, treatment, and prevention. The development of advanced neuroimaging methods is an important area of progress in neuroscience.
With the development of functional MRI (fMRI) technologies and high-resolution imaging, magnetic resonance imaging (MRI) has improved significantly. Researchers can now examine brain activity in great detail and explore the functional links between different brain areas.
Challenges Associated with Magnetoencephalography are Hampering the Global Magnetoencephalography Market Growth
MEG systems are more expensive and specialized than other neuroimaging procedures, such as functional magnetic resonance imaging (fMRI) or electroencephalography (EEG). MEG systems are costly to run, maintain, and staff with the appropriate expertise in addition to the original purchase.
MEG infrastructure is not as widespread as that of other imaging modalities. Because of this shortage, it is challenging for researchers and clinicians to get access to MEG resources, particularly in specific places or healthcare settings. It may limit the utility of MEG in both research and therapeutic contexts.
Market Size and Growth Analysis:
According to the latest research report published by DataM Intelligence, the Global Magnetoencephalography Market was valued at US$ 273.8 million in 2022 and is projected to reach US$ 408.8 million by 2030. The market is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).
Technological Advancements Provide Lucrative Opportunities
The MEG market has seen significant technological advancements aimed at improving system performance, ease of use, and patient comfort. These include the development of advanced sensor arrays, noise reduction techniques, improved data analysis algorithms, and integration with other imaging modalities such as magnetic resonance imaging (MRI) and electroencephalography (EEG).
Increasing Adoption in Healthcare
The use of MEG in clinical practice is gradually expanding as more healthcare providers recognize its diagnostic and therapeutic potential. The ability of MEG to provide precise functional brain mapping is driving its adoption in neurosurgery planning, optimizing treatment strategies, and monitoring disease progression.
Competitive Landscape:
These businesses concentrate on product innovation, quality control, marketing tactics, and distribution network growth to keep a competitive advantage in the market. Key players often use partnerships, collaborations, mergers, and acquisitions to improve their market positions.
The major companies in the global magnetoencephalography market include
- Compumedics Limited
- MEGIN
- Ricoh USA, Inc.
- CTF MEG INTERNATIONAL SERVICES LP
- FieldLine Inc.
- Cerca Magnetics Limited, and Croton healthcare
Ricoh USA, Inc.
At Ricoh, they empower their customers to respond to a changing world with actionable insights by capturing, connecting, and securing their information.
Advances in brain imaging technology, such as Magnetoencephalography (MEG), enable us to see and explore the living brain. The RICOH MEG detects faint signals within the brain, providing a mapping of brain activity to be able to measure electromagnetic activity deep within the brain. With this type of brain scanner, clinicians and researchers can explore the inner regions of the brain that could hold answers to treatments and, hopefully, cures for debilitating neurological conditions.
To know More Download Sample
